tiprankstipranks

Eric J Ende Insider Profile

11 Followers
Eric J Ende, Director at Matinas BioPharma, holds 167.90K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 144.09K shares in Matinas BioPharma (Ticker: MTNB), holds ― shares in Progenics (Ticker: PGNX). Most recently, Eric J Ende Bought ― shares of Avadel Pharmaceuticals on May 19, 2023 for an estimated value of 181.09K.
tipranks
Eric J Ende

Eric J Ende
Matinas BioPharma (MTNB)
Director

Ranked #209 out of 98,624 Corporate Insiders

Profitable Transactions

100%
6 out of 6 Profitable Transactions

Average Return

+187.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
99.15%
0.85%
0.00%
A breakdown of Eric J Ende's holdings

Insider Roles

Avadel Pharmaceuticals
(AVDL)
Director
Matinas BioPharma
(MTNB)
Director
NeuBase Therapeutics
(NBSE)
Director
Roles that Eric J Ende holds in companies

Most Profitable Insider Trade

Stock:
Avadel Pharmaceuticals
(AVDL)
Rating:Informative Buy
Date:May 31, 2022 - May 31, 2023
Return:+526.60%
The most profitable trade made by Eric J Ende

Eric J Ende's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Matinas BioPharma
Jun 24, 2021
Director
Uninformative Buy
$26.22K
Avadel Pharmaceuticals
May 19, 2023
Director
Informative Buy
181.09K
$3.07M
PGNX
Progenics
NeuBase Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Eric J Ende's performance on stock

Eric J Ende insider profile FAQ

What is the percentage of profitable transactions made by Eric J Ende?
The percentage of profitable transactions made by Eric J Ende is 100%.
    What is the average return per transaction made by Eric J Ende?
    The average return per transaction made by Eric J Ende is 187.80%.
      What stocks does Eric J Ende hold?
      Eric J Ende holds: MTNB, AVDL, PGNX, NBSE stocks.
        What was Eric J Ende’s latest transaction?
        Eric J Ende latest transaction was an Informative Buy of $181.09K.
          What was Eric J Ende's most profitable transaction?
          Eric J Ende’s most profitable transaction was an Informative Buy of AVDL stock on May 31, 2022. The return on the trade was 526.60%.
            What is Eric J Ende's role in Matinas BioPharma?
            Eric J Ende's role in Matinas BioPharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.